“The existing scenario has exposed some structural weaknesses from the EU’s medicines provide chain and also a substantial dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides stated. She recommended that provide chain difficulties be tackled within an EU pharmaceutical method expected to be released by the tip fr… Read More